The week kicked off with a major Israeli medtech exit. U.S.-listed medical device company Artivion (NYSE: AORT) announced Monday it is exercising its option to acquire full ownership of Israeli startup Endospan in a deal valued at up to $335 million. The base purchase price is $175 million in cash, with up to $200 million in additional contingent consideration tied to commercial performance.
Endospan, founded in 2009 by Rafi Benary and Alon Shalev, develops implantable stent systems for aortic diseases. The acquisition was triggered by the FDA's April 2026 approval of Endospan's Nexus catheter-based system for treating aortic arch pathologies. The deal joins a string of notable exits in recent weeks.
Weekly Roundup: Big Deals in Cyber and Medtech
Just last week, Akamai acquired Israeli AI browser security startup LayerX for $205 million in cash. About two weeks earlier, Cisco completed its acquisition of Astrix Security — an Israeli AI cybersecurity startup specializing in Non-Human Identity (NHI) security — for approximately $400 million.
In travel tech, South Korea's HBX Group acquired Israeli startup Bridgify in a deal that could reach hundreds of millions of dollars based on performance milestones.
Funding Rounds: Quantum, Cyber, and AI Lead the Way
The past two weeks have seen several standout raises. NVision Imaging Technologies, an Israeli-German quantum healthcare company, raised $55 million in a Series B round led by Abbott, with participation from Playground Global, Entrée Capital, and others. The company is expanding from quantum MRI sensing into quantum computing for drug discovery and therapy validation.
Frame Security — a cybersecurity startup founded by former Wiz and Team8 executives — emerged from stealth with $50 million led by Index Ventures and Team8. The company is building an AI-powered platform for employee training against phishing and deepfake attacks, targeting the persistent human-factor weakness in enterprise security.
Kela Technologies, an Israeli startup developing an operating system for modern militaries, raised $200 million in a Series C at a $1.2 billion valuation. Novella raised $21 million to automate complex insurance with AI brokers, and CopilotKit secured a $20.5 million Series A to help developers build and deploy AI agents.
The Big Picture: An Ecosystem in Recovery Mode
Year-to-date through mid-May 2026, Israeli startups have raised approximately $1.69 billion across 63 equity rounds — down 21% from the same period in 2025. However, Q1 2026 alone saw $3.1 billion raised across 98 rounds, up 34% year-over-year. April stood out with over $1.25 billion, marking the strongest April since 2021.
Global Giants Deepen Their Israel Presence
Meanwhile, multinational tech companies continue to expand their Israeli R&D footprint. R&D centers run by Google, Amazon, Microsoft, Apple, Nvidia, Intel, and others employ nearly 90,000 people across Tel Aviv, Haifa, and Be'er Sheva. These centers focus on deep tech: AI, quantum computing, semiconductors, biotechnology, and cloud infrastructure.
U.S. semiconductor company Astera Labs opened a new R&D hub in Tel Aviv and Haifa in February 2026, with plans to hire hundreds of engineers by end of 2027. The company specializes in high-performance connectivity solutions for AI infrastructure.
Bottom Line
The Israeli tech ecosystem continues to demonstrate resilience: major exits in cyber and medtech, significant funding rounds in quantum and AI, and steady expansion of multinational R&D centers. The combination of local engineering talent and global capital positions Israel as an innovation hub that keeps thriving even in a challenging environment.
